Description
NSE Clearing has issued a revised settlement calendar for the buyback offer under tender offer scheme by Nectar Lifesciences Limited, modifying the obligation download and settlement dates.
Summary
NSE Clearing Limited has issued a revised settlement calendar for the buyback offer under tender offer scheme by Nectar Lifesciences Limited. This circular supersedes the settlement dates mentioned in earlier circulars NCL/CMPT/72058 dated December 30, 2025, and NSE/CMTR/72034 dated December 29, 2025. The revision updates the obligation download and settlement dates while maintaining other details from the original circular.
Key Points
- Revised settlement calendar issued for Nectar Lifesciences Limited buyback offer
- Settlement Type: X, Settlement Number: 2025136
- Trade period: December 31, 2025 to January 6, 2026
- Updated obligation download date: January 12, 2026
- Updated settlement date: January 13, 2026
- Clearing Corporation may notify further revised schedule in case of delays from RTA or buying trading member
- All other details from circular NCL/CMPT/72058 dated December 30, 2025 remain applicable
Regulatory Changes
No new regulatory changes introduced. This circular provides a revised timeline for an existing buyback offer under the tender offer scheme framework.
Compliance Requirements
- Members, Custodians, and PCMs must note the revised settlement calendar
- Trading members must ensure timely funds pay-in to avoid further schedule revisions
- Participants should monitor for potential additional schedule changes if delays occur in acceptance details receipt from RTA or funds pay-in
Important Dates
- Trade Start Date: December 31, 2025
- Trade End Date: January 6, 2026
- Obligation Download: January 12, 2026
- Settlement Date: January 13, 2026
Note: Dates marked with asterisk are subject to change in case of delays in receipt of acceptance details from RTA or delay in funds pay-in by buying trading member.
Impact Assessment
Market Impact: Limited to participants involved in the Nectar Lifesciences Limited buyback offer. The revised schedule provides two additional days for obligation download and settlement compared to what would typically be expected.
Operational Impact: Trading members and custodians dealing with Nectar Lifesciences shares under this tender offer must update their internal systems and processes to reflect the new settlement timeline. Risk management and fund allocation schedules may need adjustment.
Contact Information: For clarifications, members can contact NCL help desk at toll-free number 1800 266 00 50 (Option 2) or email ncl_tenderoffer@nsccl.co.in.
Impact Justification
Revised settlement schedule for a specific buyback offer affects trading members and participants dealing with Nectar Lifesciences shares. Medium impact as it relates to a single corporate action with modified timelines.